Targeting FBXL5 to induce ferroptosis and reverse oxaliplatin resistance in iron-rich colorectal cancer.

oxaliplatin - Generic mfg.

erastin - Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Columbia University, Prolexys

http://www.ncbi.nlm.nih.gov/pubmed/41136490

Feifei Wen; Miaomiao Wang; Ruizhe Zhang; Shuang He; Shuhua Wu; Xiaojie Yu; Xiaoyang Xu; Yangyang Li

Oct 27, 2025